Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
S. aureus vaccine development has proven particularly difficult. The conventional approach to achieve sterile immunity through opsonophagocytic killing has been largely unsuccessful. S. aureus is highly toxigenic and a great body of evidence suggests that a successful future vaccine for this organis...
Main Authors: | Rajan P Adhikari, Thomas Kort, Sergey Shulenin, Tulasikumari Kanipakala, Nader Ganjbaksh, Mary-Claire Roghmann, Frederick W Holtsberg, M Javad Aman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4569305?pdf=render |
Similar Items
-
Correction: Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
by: Rajan P Adhikari, et al.
Published: (2015-01-01) -
Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins.
by: Machi Yanai, et al.
Published: (2014-01-01) -
Rational Design of Toxoid Vaccine Candidates for <i>Staphylococcus aureus</i> Leukocidin AB (LukAB)
by: Shweta Kailasan, et al.
Published: (2019-06-01) -
Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.
by: Hatice Karauzum, et al.
Published: (2013-01-01) -
Staphylococcal Bicomponent Pore-Forming Toxins: Targets for Prophylaxis and Immunotherapy
by: M. Javad Aman, et al.
Published: (2014-03-01)